eduda

Ernő Duda

SOLVO Biotechnology

Member Profile

Ernő is the CEO, president and co-founder of SOLVO Biotechnology,
Hungary’s largest independent biopharmaceutical company. He is also
founder and president of the Hungarian Biotechnology Association, a
representative organization that actively lobbies on behalf of the
interests of its member companies and the biotechnology sector in
Hungary. As an entrepreneur, Ernő has founded or co-founded 13
companies in the past 15 years, including a corporate finance
consulting company focused on high-tech Hungarian start-ups and
Hungary’s largest online second-hand bookstore. He was vice president
of the American Chamber of Commerce in Hungary in 1998 and 1999 and
president of the Junior Achievement Foundation Hungary from 1997 to
2006.

Ernő is a member of the Research and Technology Innovation Council,
the Board of Trustees of the Bay Zoltán Foundation for Applied
Research, and the Board of the Hungarian Association for Innovation.
He has taught English, applied economics and management studies.
Presently he is an invited lecturer at the University of Szeged, where
he teaches a course entitled “Biotechnology from a Business
Perspective.”

Member nationality:

Hungary

Company Profile

Established in 1999, SOLVO Biotechnology is a privately held company
specializing in pharmaceutical and biotechnological R&D related to ABC
transporters and multi-drug resistance in cancer and other diseases.
The company was founded by internationally reputed Hungarian
scientists and business executives. Over 75% of SOLVO is in the hands
of Hungarian firms and individuals. International business angels own
the rest.

SOLVO’s professional team of over 70 experts consists of medical
doctors, pharmacists, biologists, chemists and economists. The
company’s laboratories are located in the Biological Cooperation
Center of the University of Szeged and the Central Hungarian
Innovation Center in Budaörs. These laboratories perform the company’s
own research and development activities, as well as contract research
and production for international pharmaceutical companies.

SOLVO’s mainstream products are its in-vitro assay systems designed
for sale by pharmaceutical companies in the EU, Japan and the US.
Manufactured exclusively by SOLVO worldwide, most of these products
are protected by patents, know-how, or trade secrets. The 20 largest
pharmaceutical and most significant biotechnology companies are
regular users of SOLVO’s assay systems. The company also develops
diagnostic products that help physicians personalize chemotherapy
treatment for patients with cancer and other diseases. SOLVO has early
stage drug discovery projects as well.

Company industry sector:

Health/Life Sciences

Company nationality:

Hungary